arrow-circle-full-right arrow-circle-full-up arrow-circle-up arrow-down arrow-right calendar calendar-done facebook flickr home linkedin login pin reload search share signin star twitter video video youtube nav star-plus info signout double-arrow arrow-up checked
Healthcare & Life Sciences, Telecoms, Media and Technology

FT Digital Health Summit Europe

From Fragmentation to Integration

Berlin |
Speakers include:
Gottfried Ludewig

Gottfried Ludewig

Federal Ministry of Health

Peter Gocke

Peter Gocke

Charité University Medical Center

Eve Roodhouse

Eve Roodhouse

NHS Digital


The latest instalment of the FT’s Digital Health Summit Europe will be held in Berlin and will home in on the approaches, investment and frameworks needed to implement connected health solutions. Health leaders will share their experiences and vision for delivering digitally-driven integrated care.

fallback Add to my Calendar 06/19/2018 08:00:0006/19/2018 18:00:00trueFT Digital Health Summit Europe The latest instalment of the FT’s Digital Health Summit Europe will be held in Berlin and will home in on the approaches, investment and frameworks needed to implement connected health solutions. Health leaders will share their experiences and vision for delivering digitally-driven integrated care.FT-Digital-Health-Summit-Europe-87d82e0716f9479f28ac4c5f7bd1d3a8MM/DD/YYYY

Untitled Block

All sessions will be delivered in English, unless otherwise stated.


Executive Summary


Download now

Event Brochure

To download the event brochure please fill in the form below. All fields are required

Please complete all the highlighted fields

Form submission failed. Please retry.

Data Protection

By submitting this form you consent to being contacted by FT Live about this event by phone and email.

Thank you for submitting your details. Please download the event brochure.

2017 Testimonials

"Excellent speakers and well organised. I will definitely come again.” Nick Hirst, CIO, NIHR CRNCC

 “Excellent 1-day snapshot of the key issues in digital health.” Ed Currie, Smart Health Ambassador, TM Forum

 “Thanks a lot for the opportunity to be a part of this extraordinary event. It really has been a pleasure. Looking forward to see you again in the future”  Karl Pall, Director, Google

 “Excellent platform to have an open, frank discussion in an environment that is so traditional and fixated, yet cutting-edge in so many ways.” Khilona Radia, CEO, Antrum Biotech

 “High quality speakers” Lars Dahle, CEO, Dignio


Full Overview

Fragmentation in healthcare and the lack of coordination between departments and services are major barriers to be overcome as the transformation of health gathers pace across Europe. Digital technologies have the power to connect and integrate isolated and disparate services and deliver more intuitive and coordinated patient experiences.  However, with the huge number of new technologies, devices and applications, and growing amounts of data, there is the risk that digital innovations will add to the fragmentation if the issues of interconnectivity, security and access are not addressed.

The keynotes, interviews, panels and debates will explore how technology can help to unite the fragments, strengthen systems, and improve patient experiences and outcomes throughout the continent.  


Speakers (26)

Gottfried Ludewig

Gottfried Ludewig

Head of Directorate General of Digitalisation and Innovation
Federal Ministry of Health

Gottfried Ludewig is the Head of the Directorate General of Digitalisation and Innovation at the German Federal Ministry of Health, formed in April 2018. Previously, Dr Ludewig was a member of the Berlin House of Representatives and Vice Chairman of the CDU Parliamentary Group (2011-2018). In the last position, his focus was especially dedicated to strengthen the areas of research and innovation in the German healthcare sector. Dr Ludewig studied Economics at Berlin Technical University, where he also graduated with his Doctoral thesis on the Regulatory Framework of the German Health Insurance Sector. He has worked as Senior Consultant for Pricewaterhouse Coopers and was Federal Chairperson of the German Association of Christian Democrat Students (RCDS) from 2008 to 2010.

Peter Gocke

Peter Gocke

Chief Digital Officer
Charité University Medical Center

In April 2017 Peter Gocke was appointed as the first Chief Digital Officer (CDO) in the healthcare provider space in Germany. In this role, he is responsible for the digital transformation of the Charité, the academic hospital in Berlin, which is the largest AMC in Germany. Previously, Dr Gocke was the Director of IT (CIO) & process management (CPO) at Amedes AG, a large laboratory service provider and prior to that he was the CIO of the Academic Medical Center in Hamburg. In his former CIO position in Hamburg, he was in charge of several digitalization projects, which led to a first HIMSS EMRAM stage 7 award for a European hospital. He is a trained radiologist holding previous roles as Associate Professor of Radiology.

Eve Roodhouse

Eve Roodhouse

Director for Implementation and the Digital Environment
NHS Digital

Eve Roodhouse is Interim Director for Implementation and the Digital Environment at NHS Digital and Chair of the NHS Digital Women’s Network. She is passionate about supporting the NHS and Local Authorities to make the most of digital products and services and working with colleagues across the organisation to ensure NHS Digital becomes more responsive to its customers. Ms Roodhouse established the new Implementation and Business Change function in April 2017 which remains part of her portfolio and takes the lead on Digital Skills. She has more than 17 years of experience working in complex delivery environments (14 being in NHS informatics), with a breadth of experience that takes in all aspects of the programme management lifecycle from stakeholder engagement, business case development, procurement and supplier management, to software development, change management and managed closure.

Ms Roodhouse graduated from the Major Project Leadership Academy in February 2016. She started her career as a management consultant at Deloitte where she worked at Transport for London on the successful delivery of the London congestion charging scheme.

Xavier Prats Monné

Xavier Prats Monné

Director-General for Health and Food Safety
European Commission

Xavier Prats Monné has been the Director-General for Health and Food Safety of the European Commission since September 2015. He is responsible for EU policies and programmes in health and food safety, including the promotion of public health, the assessment of national healthcare systems' performance, pharmaceutical legislation, animal health and welfare, as well as the strengthening of Europe's capacity to deal with crisis situations in human health and the food sector. He previously served as Director-General for education and culture and as Director for employment policy.

He holds degrees in Social Anthropology from the Universidad Complutense (Madrid, Spain); in Development Cooperation from the International Centre for Advanced Mediterranean Agronomic Studies (CIHEAM; Paris, France); and in European Studies from the College of Europe (Bruges, Belgium), where he graduated first of the Class of 1981-82 and served as assistant professor.

Penelope Dash

Penelope Dash

Senior Partner
McKinsey & Company

Penny Dash leads McKinsey’s healthcare work across Europe with a focus on redesigning services to improve quality and efficiency of care delivery. Ms Dash has over 20 years’ experience in health care consulting and also spent time as Head of Strategy for the NHS. From 2004 to 2006 she was a non-executive Director of Monitor, the Independent Regulator for Hospitals in England and served as a Trustee and Vice Chairman of the King’s Fund from 2006 to 2014.

Ms Dash originally trained as a doctor in Cambridge and London and is a Fellow of the Royal College of Physicians of London. She has an MSc in Public Health Medicine and a MBA from Stanford Business School where she was a Fulbright Scholar.

Marie McCarthy

Marie McCarthy

Senior Director Product Innovation

Marie McCarthy is part of the multidisciplinary Innovation Team at ICON plc.  Seen as a key Intrapreneur within the organisation she has specific responsibility for developing solutions in the direct to patient paradigm. Her focus is primarily on the use of wearables and sensors in clinical trials, with particular emphasis on the potential these devices have to monitor the physical behaviours of the digital patient.  Ms McCarthy has a background in scientific research and has worked in a number of industries including IVD and Medical Devices.  She is a published author and spoken at a number international conferences.   She acts in an advisory capacity for a number of sponsors on the relevant clinical endpoints and considerations to be deployed when embarking on the incorporation of wearable technology into clinical trials. As part of the ICON CNS innovation group she provides insight into outcomes addressed by wearable technology.  Within the Innovation team she has been directly responsible for the running of a number of proof-of-concepts including a number of multi-sensor studies.  She has written and contributed to numerous articles focusing on use many of which are on the use of wearables in clinical trials. 

Chen Admati

Chen Admati

Head of Intel® Pharma Analytics Platform

Chen Admati is the head of Intel® Pharma Analytics Platform at Intel. Intel® Pharma Analytics Platform is an edge-to-cloud artificial intelligence platform for remote monitoring of patients during clinical trials using wearable and sensors. Using big data and machine learning techniques, the platform enables to quantify the impact of therapies, promise to transform research and drug development in various chronic diseases. Prior to leading Intel® Pharma Analytics Platform, Ms Admati managed various artificial intelligence solutions and services in various domains. She is AI professional, brings vast of understanding in the healthcare domain, and how to successfully digitize clinical trials.

Alberto Tozzi

Alberto Tozzi

Chief Innovation Officer
Bambino Gesù Children's Hospital

Alberto Tozzi is a pediatrician and an epidemiologist with experience in vaccines and epidemiology of transmissible diseases. He has worked as a researcher with the Italian National Health Institute for more than 15 years, participating and coordinating several projects concerning the prevention and surveillance of infectious diseases. In 2004 Dr Tozzi moved to the Bambino Gesù Children’s Hospital, where he continued to work in vaccine preventable diseases and started developing projects on eHealth and digital medicine. Dr Tozzi is serves the Bambino Gesù Children’s Hospital as Chief Innovation Officer and is head of the Multifactorial and Complex Diseases Research Area. He is responsible for the development of telemedicine programmes within the Hospital. Among the others, he followed a project on pattern of contacts in a pediatric ward measured through wearable RFID tags explaining the diffusion of infectious diseases, and studies on the prediction of influenza and rhinoconjunctivitis through Twitter analysis. He represents the Bambino Gesù Children’s Hospital in the International Society for Pediatric Innovation. He also collaborates with the WHO Vaccine Safety Network for a programme on data driven communication.

John  Moore

John Moore

Director, Customer Lab

John Moore began his career putting Australia’s Northern Territory on the tourist map before joining the National Australia Bank. It was there the trained economist discovered his talent for using data to solve customer’s problems, going on to transform the brand and customer experiences of Canada’s Scotiabank and CIBC, telecoms giant Vodafone, and Australian businesses, Suncorp and Australia Post. These days, Mr Moore is focused on finding ways of helping Bupa's customers live longer, healthier, happier lives.

David Liverseidge

David Liverseidge

Chief Information Officer
Nuffield Health

David Liverseidge took up the position of Chief Information Officer in January 2017. Prior to this he had been leading the organisation’s business technology agenda in the Hospitals area, initiating a programme of work now in flight to deliver an integrated Electronic Health record for the organisation. He is passionate about the application of technology to improve customer experience, transform the way the business operates and improve the lives of Nuffield Health’s customers, members, patients and partners. Mr Liverseidge’s previous experience covers a variety of industries where he has held a variety of UK and international technology related leadership roles at organisations such as AstraZeneca and Sony Corporation. He started his career in IT consulting with Price Waterhouse.

Milind Kamkolkar

Milind Kamkolkar

Chief Data Officer

Milind Kamkolkar is the CDO of Sanofi, a company focused on empowering lives through human health. Mr Kamkolkar’s focus is driving and transforming Sanofi from a data generation organisation to an insights generating organisation where data is a monetizable asset class on par with product and shareholder value.

Mr Kamkolkar joined Sanofi from a career spanning big pharma (Novartis), big and boutique consulting (Cognizant and PA Consulting), and numerous technology and software startup companies focused on health, technology and data mining blending insights and approaches across industries to solve complex human health problems at scale.  He is a featured speaker and thought leader in Digital Health, AI & Big Data, serves as a Board Advisor and mentor to 3 exciting start-ups hacking education/mental health, deep learning for research technologies, Honorary Lecturer for physician entrepreneurship at BartsX, Faculty at Exponential Medicine and Special Advisor to the UN Global Sustainability.

Carina Namih

Carina Namih

Episode 1

Carina Namih is a Partner at Episode1 Ventures, where she invests across the latest trends in: health technology, computational biology, AI, VR, blockchain and robotics. Ms Namih spent 5 years in Silicon Valley, where she founded HelixNano with a team from MIT – applying AI to genetic data. She is an alumnus of YCombinator, Singularity University and Oxford University. She sits on the curatorial committee of the ScienceGallery in London. Previously, Ms Namih was an Entrepreneur-in-Residence at Johnson&Johnson Innovation and an M&A advisor with Goldman Sachs. 

Felicitas Riedl

Felicitas Riedl

Head of Life Sciences Division
European Investment Bank

Felicitas Riedl is the Head of the Life Sciences Division at the European Investment Bank in Luxembourg, responsible for the life sciences, health and pharmaceutical sectors in the Projects Directorate of the Bank. Prior to this, Ms Riedl was a Life Sciences Specialist in the same division. Previously, she worked at the European Investment Fund as an Investment Manager with a particular focus on technology transfer. Her main tasks there were the analysis of technology transfer, the development of financial vehicles targeting this particular area and the implementation of these funding structures.

Prior to that, Ms Riedl worked as a strategy consultant for L.E.K. Consulting in Munich and Los Angeles. There, she focused on Private Equity / M&A and Life Sciences. Her work included business planning, market research, development of market entry strategies as well as financial and commercial due diligences.

She earned a Master of Science from the Philipps University of Marburg and Stanford University in Palo Alto with a major in human genetics and molecular biology.

Sohini Chowdhury

Sohini Chowdhury

Deputy CEO
The Michael J Fox Foundation for Parkinson's Research

Sohini Chowdhury joined The Michael J Fox Foundation in 2005. As Deputy CEO, she oversees the Research Partnerships team and works closely with the Foundation's executive leadership and Board of Directors in building the organization’s capacity as an unprecedented stakeholder in drug development — a nimble, resourceful, patient-focused problem-solver whose efforts are demonstrably accelerating progress toward treatment breakthroughs and a cure. Ms Chowdhury  was elevated to the role of Deputy CEO in 2017. In her previous capacity as SVP, Research Partnerships at the Foundation, she established and led the formal industry strategy, building ongoing relationships with pharmaceutical firms and biotechs as research partners and as sponsors of the Foundation’s scientific and educational programs. She has led development of programs critical to increasing patient engagement in Parkinson’s research including the Fox Trial Finder smart-match tool and Fox Insight.  Ms Chowdhury also is responsible for administrative and operational oversight of the MJFF-sponsored landmark clinical study PPMI, or the Parkinson’s Progression Markers Initiative, launched by MJFF in 2010 to identify and validate Parkinson’s biomarkers. Prior to joining MJFF, she worked at the World Economic Forum for five years. As the Senior Community Manager of the Forum's Technology Pioneers program, she was responsible for annually selecting and integrating innovative biotech, energy and IT technology companies into Forum activities.  She also worked directly for the Forum's CEO, acting as his liaison with key Forum stakeholders and overseeing several in-house projects.  Ms Chowdhury graduated with an MA from Georgetown University, and holds a BA in International Studies from Vassar College.

Henk de Jong

Henk de Jong

Chief of International Markets

Henk de Jong was appointed Chief of International Markets in April 2017 with responsibility for results of customer-facing activities across the world (with the exception of North America and Greater China). He is also a member of the Board of Philips Capital N.V.  Mr de Jong joined Philips in 1990. His most recent role was Market Leader in Latin America (LATAM). He also led major transformations in our businesses across the region. Among his achievements, he drove productivity implementing LEAN; led a more a customer-centered approach in our Personal Health businesses and oversaw shift towards a more innovative solutions-based approach in our Health Systems businesses. Prior to that he held a number of leadership roles in Philips’ former Consumer Lifestyle businesses in Europe and Asia.

He holds an MBA from the Rijksuniversiteit Groningen and graduated in Finance for Senior Executives at Harvard Business School. He has also taught transformation management at ISE business school in São Paulo.

Mathias Goyen

Mathias Goyen

Chief Medical Officer, Europe
GE Healthcare

Mathias Goyen is responsible for leading GE Healthcare’s medical, clinical and evidence generation strategies for product modalities in Europe. Together with his team he provides leadership in healthcare economics and outcomes research and comparative effectiveness research to develop customer value propositions for new and existing products.

Dr Goyen began his career as a diagnostic Radiologist working at Essen and Hamburg, Germany. He was appointed Professor of Diagnostic Radiology at the University of Hamburg in 2010. His previous experience also includes 5 years as Managing Director of UKE Consult and Management GmbH, a subsidiary of the University Medical Center Hamburg, where he was responsible for the overall consulting and foreign business of the University Medical Center Hamburg. Together with the leadership team of the hospital Dr Goyen established a Comprehensive Cancer Center linking clinical medicine with new oncologic research strategies. He holds a medical degree from the University of Bochum, Germany.

Erwin  Böttinger

Erwin Böttinger

Head, Digital Health Center, Professor for Digital Health and Personalized Medicine,
Hasso-Plattner Institute

Erwin Böttinger is Professor for Digital Health - Personalized Medicine and Head of Digital Health Center at the Digital Engineering Faculty of the Hasso Plattner Institute (HPI) GmbH at the University of Potsdam. He is the founding director of the HPI Digital Health Center. From November 2015 to July 2017 Prof Dr Böttinger was the CEO of the Berlin Institute of Health (BIH). Prof Dr Böttinger is considered an international expert in personalized medicine and digital health, in particular for his performance as founding director of the Charles Bronfman Institute for Personalized Medicine at the Icahn School of Medicine at Mount Sinai in New York, USA, from 2005 to 2015.

Teemupekka  Virtanen

Teemupekka Virtanen

Senior Adviser, National eHealth Services
Ministry of Social Affairs and Health, Finland
Matthias Evers

Matthias Evers

Senior Partner
McKinsey & Company

Matthias Evers is a Senior Partner of McKinsey, based in Hamburg. A molecular biochemist and bioinformatician by training, he is co-leader of McKinsey’s Global Pharmaceuticals and Medical Products (PMP) R&D and Medical Practice.

Dr Evers has directed projects in Europe, the United States, India, and China; always helping biotech, pharmaceutical and medtech companies in their quest for innovation, driving R&D productivity, defining drug and asset strategies, and striving for excellence in core functions, from drug discovery to medical and regulatory affairs. Fuelled by the passion to innovate for patients, he is putting energy into cross-industry activities in pursuit of innovation, specifically to create more science leadership capacity, advancing digital/analytics in R&D as well as excellence in Medical to serve patients best. He authored several articles in the field of bioinformatics, molecular biology, and R&D productivity.

Mitchell Silva

Mitchell Silva

Patient Advocate

Mitchell is a patient advocate with a long term condition. Based on his experience as a patient in combination with his experience as a researcher, he started to develop tools to follow his condition over time. Mitchell is also co-founder of Esperity, a platform to encourage patients to find peer support, find clinical trials and to promote self-tracking. He participates in and organising patient partnership programs aiming at including patient input during the design phase of new services for patients. Mitchell is also the chair of the Belgian EUPATI national platform and a board member of ReumaNet. He has a PhD in bio-engineering from the KULeuven. 

Christian Lautner

Christian Lautner

Co-founder and Managing Partner
Flying Health

Christian Lautner is Co-founder and Managing Partner at Flying Health, focusing on serious digital health technologies i.e. digital biomarkers and digital therapies.

Previously, he co-founded one of the first German doctors rating platform and later joined as CEO to work towards comparability of hospital quality accessible for everyone via digital devices.

Kristian Hart-Hansen

Kristian Hart-Hansen

LEO Innovation Lab

Kristian Hart-Hansen is the CEO of LEO Innovation Lab, an independent unit of LEO Pharma, established to focus on cultivating new technology to better understand health, and to enable patients to prevent, detect and manage chronic skin conditions. LEO Innovation Lab’s mission is to harness the power of data, to help patients lead happier lives. Under Mr Hart-Hansen’s leadership, LEO Innovation Lab has built six innovative digital platforms in under two years, focusing on a wide range of healthcare areas - from the automisation of clinical trial recruitment, to a functioning artificial intelligence that can aid clinical recommendations. Mr Hart-Hansen’s vision is to nurture a clinical journey that is more adaptable, patient-driven, and most importantly, more efficient.

Diana Heinrichs

Diana Heinrichs

CEO and Co-founder

Diana Heinrichs, CEO and Co-founder of Berlin-based Lindera, has developed the first data science tool for the point of care. Her experience at Microsoft Deutschland on the future of the digital world of work helped her to frame the question – how can older people live longer and independently at home?

Virgilio Bento

Virgilio Bento

Founder and CEO
Sword Health

Virgilio Bento founded SWORD Health in 2014, while undergoing his PhD in electrical engineering. Each year, more than 230 million people require physical rehabilitation for common musculoskeletal disorders alone, and ageing populations worldwide are only expected to exacerbate this problem. Recognising that the demand for rehabilitation vastly outweighed supply, and fuelled by his own experiences following his brother’s accident and rehabilitation at the CIREN centre in Cuba, Dr Bento realised that technology and data sharing offered a solution that kept the personal relationship intact. SWORD Health’s flagship product, SWORD Phoenix, is an AI-powered digital physiotherapist that grants patients access to high-intensity physiotherapy from the comfort of their homes. Through SWORD Phoenix, patients have access to intensive, task-specific rehabilitation protocols at home, ultimately ensuring better patient outcomes. Clinical trials have found that 93% of patients demonstrated improvement in the quality of motor tasks when using the platform. SWORD Health is currently operating in the USA, Canada, Australia, Norway and Portugal, and has raised $6 million in funding so far. In addition to his work for SWORD, Dr Bento holds multiple patents, has co-authored more than 40 research papers, and has founded several start-ups from his home city of Porto, Portugal.

Sophie Bostock

Sophie Bostock

UK Innovation Lead
Big Health

Sophie Bostock is UK Innovation Lead at Big Health the company behind digital sleep improvement programme, Sleepio.  Big Health is a digital medicine company with a mission: to help millions of people back to good mental health. Dr Bostock has been awarded an NHS Innovation Accelerator Fellowship to help promote the uptake of digital medicine in the NHS.  As Innovation Lead, she works with partners in the NHS to identify opportunities to transform patient care, resolve barriers to uptake, and to build compelling evidence for wider adoption.  Dr Bostock has a PhD in Health Psychology from UCL and her research interests include the links between sleep, well-being, health and performance.

Claudio Hasler

Claudio Hasler

Co-founder and CEO

Claudio Hasler is Co-founder and CEO of PeakProfiling - a pioneer in speech sound analysis. Based on more than 20 years of research, the company is able to detect mental and physical disorders from the sound of the human voice. Previously, Mr Hasler was leading the Business Intelligence and Analytics departments as well as all digital activities of one of the largest German OTC players. Moreover, he has been working for Google in various roles, e.g. as Industry Manager.



Sarah  Neville

Sarah Neville

Global Pharmaceuticals Editor
Financial Times

Sarah Neville began her career on local and regional newspapers, eventually becoming political editor of the Yorkshire Post. In 1995 she was awarded the Laurence Stern Fellowship on the Washington Post. She joined the Financial Times in 2001 and has since held a series of senior roles, including Weekend News Editor, Analysis Editor, UK News Editor and public policy editor in 2011. She was appointed Pharmaceuticals Correspondent in 2016.

David  Crow

David Crow

Senior US Business Correspondent
Financial Times

David Crow is a Senior US Business Correspondent for the Financial Times, covering telecoms, technology, and pharmaceuticals. He is based in New York. He previously worked on the FT's main news desk in London, where he edited the front page of the print edition. Before joining the FT he was Managing Editor of City AM, the London financial newspaper.

Mr Crow has an MA in English Literature from the University of Glasgow.

Agenda - 19th Jun

  • 8:00am
    Registration and networking
  • 8:50am
    Chair’s opening remarks

    Sarah Neville, Global Pharmaceuticals Editor, Financial Times

  • 9:00am
    Opening address: Digital Health in Europe – creating opportunities for our health systems

    Gottfried Ludewig, Head of Directorate General of Digitalisation and Innovation, Federal Ministry of Health

  • 9:20am
    Health leaders’ panel: Perspectives on integrated healthcare delivery

    Healthcare services across Europe are facing challenges around cost, security, engagement and integration. During this opening panel, European health leaders will share perspectives on overcoming vulnerabilities and discuss best practices for realising a smooth transition to ‘mainstream’ digital health.

    • Ways of creating smarter systems that are useful, usable and used. How far, how fast and at what scale can the transition to digital health be made?
    • What are the difficulties of combining technologies from different providers into one integrated healthcare experience for the patient?
    • How is the digital transition being paid for?
    • How can healthcare professionals keep up with the new wave of technological innovation?
    • Initiatives to equip the workforce with skills, knowledge and experience

    Keynote:  Eve Roodhouse, Director for Implementation and the Digital Environment, NHS Digital


    Peter Gocke, Chief Digital Officer, Charité University Medical Center

    Xavier Prats Monné, Director-General, Directorate-General for Health and Food Safety, European Commission

    Teemupekka Virtanen, Senior Adviser, National eHealth Services, Ministry of Social Affairs and Health, Finland

    Moderator: Sarah Neville, Global Pharmaceuticals Editor, Financial Times

  • 10:20am
    Keynote Interview
  • 10:40am
    Networking break
  • 11:00am
    Discussion Panel: Breaking down the data silos

    Historically, the fragmented nature of health systems in Europe has made it difficult to share information, and with more and more data sets being created in isolation, the proliferation of big data is adding to the fragmentation. This session will explore ways of tackling the integration challenges to ensure that the data acquired by doctors, hospitals, laboratories and technology companies is shared and exploited securely and for the benefit of the patient.

    • Who owns and controls the data and how can it be shared safely and flow freely across the health spectrum?
    • Building transparency and trust and the impact of changes in data protection legislation
    • Creating efficient digital pathways and getting data to where the decision making processes are taking place.
    • To what extent can the patient be put in control of their own information?
    • What can be learnt from other industries such as banking and retail about standardising and integrating data across platforms?

    Mathias Goyen, Chief Medical Officer, Europe, GE Healthcare

    Milind Kamkolkar, Chief Data Officer, Sanofi

    David Liverseidge, Chief Information Officer, Nuffield Health

    Alberto Tozzi, Chief Innovation Officer, Bambino Gesù Children's Hospital

    Moderator: David Crow, Senior US Business Correspondent, Financial Times

  • 11:50am
    Investment Panel: Balancing risk and opportunity

    In the fast-evolving digital health landscape, the pressure is on for technology developers to differentiate themselves from the competition as they seek to attract investment capital. This session will consider the extent to which digital health is continuing to be fertile ground for investment and which opportunities are exciting investors in 2018.

    • Patterns of investment: which health-tech and digital products are showing the best ROI?
    • What are investors in tech-enabled health looking for?
    • The outlook for consolidation: M&A activity and impact.
    • What will investment look like post-Brexit?

    Christian Lautner, Co-founder and Managing Partner, Flying Health

    Carina Namih, Partner, Episode 1

    Felicitas Riedl, Head of Life Sciences Division, European Investment Bank

    Moderator: David Crow, Senior US Business Correspondent, Financial Times

  • 12:40pm
    Fireside chat: Delivering value-based care

    Penelope Dash, Senior Partner, McKinsey & Company 

    Moderator: Sarah Neville, Global Pharmaceuticals Editor, Financial Times

  • 1:00pm
  • 2:00pm
    Digital health dialogue: The human approach to disruption: integrating the voice of the patient

    High on the agenda is the need to build trust and engage patients in the transformation of healthcare. Understanding what the individual wants and integrating their voice into the development phase of digital technologies and services will help to deliver more intuitive experiences and enable patients to take control of their health, diagnosis and treatment. This dialogue will focus on how collaboration is driving acceptance and engagement and putting the person at the centre of personalised health.

    Erwin Böttinger, Head, Digital Health Center, Professor for Digital Health and Personalized Medicine, Hasso-Plattner Institute

    Kristian Hart-Hansen, Chief Executive Officer, LEO Innovation Lab

    Henk de Jong, Chief of International Markets, Philips

    John Moore, Director, Customer Lab, Bupa

    Moderator: Sarah Neville, Global Pharmaceuticals Editor, Financial Times

  • 2:45pm
    Special focus:  The digital reinvention of clinical trials

    Digital technologies are starting to prove their worth in the quest to tackle costs and inefficiencies and streamline the clinical trial process. Social media, big data, wearables and mobile devices are transforming the collection and analysis of patient information. Going forward, how can clinical trials be further moved into the digital age?

    • In what ways are pharma companies adapting their R&D processes and accelerating progress towards digital drug discovery?
    • How can AI technologies, such as machine learning, be used to provide better insights, analysis and understanding of data?
    • How is regulation evolving and what barriers does it pose?
    • Could trials be conducted entirely using measurements taken with remote devices? What would this do to costs and patient engagement? And what would it mean for trial design?

    Chen Admati, Head of Intel® Pharma Analytics Platform, Intel

    Sohini Chowdhury, Deputy CEO, The Michael J Fox Foundation for Parkinson's Research

    Matthias Evers, Senior Partner, McKinsey & Company

    Marie McCarthy, Senior Director Product Innovation, ICON

    Mitchell Silva, Patient Advocate

    Moderator: Sarah Neville, Global Pharmaceuticals Editor, Financial Times

  • 3:30pm
    Networking break
  • 3:50pm
    In Conversation with the FT: Coming up with the evidence

    How to generate evidence on the effectiveness of digital technologies

  • 4:10pm
    Technology Spotlight: At the cutting edge of health transformation

    This series of brief presentations and quick-fire interviews will shine a spotlight on the innovators and trailblazers who are broadening the frontiers in prevention and treatment. Companies at the cutting edge of digital health will present what their technologies offer in terms of impact on patients and potential returns on investment and discuss their plans for market adoption and integration.

    Virgilio Bento, Founder and CEO, Sword Health

    Sophie Bostock, UK Innovation Lead, Big Health

    Claudio Hasler, Co-founder and CEO, PeakProfiling

    Diana Heinrichs, CEO and Co-founder, Lindera

    Moderator: David Crow, Senior US Business Correspondent, Financial Times

  • 5:10pm
    Closing remarks

    David Crow, Senior US Business Correspondent, Financial Times

  • 5:20pm
    Drinks reception

Why attend?

  • Assess how patients are being empowered and further involved in the transformation of healthcare
  • Hear how collaborations between pharma and big tech are enriching the commercial viability of digital health
  • Meet and greet with the full array of industry stakeholders, from healthcare to technology, pharma to start-ups, regulation to government
  • Identify solutions in overcoming cyber security threats in digital health
  • Don’t get left behind - be part of a must-attend event mapping the continued transformation of healthcare

Who attends?

FT Live has a reputation for delivering very senior board level audiences to attend a wide range of world class thought-leadership events across the globe for nearly 40 years. 

The FT Digital Health Summit Europe will be attended by: 

- Pharmaceutical and biotechnology companies 
- Healthcare Providers
- Medical Device manufacturers 
- Health insurers
- Investment banks 
- Hospital Management
- Clinicians 



Ticket Type


Early Bird Ticket (ends 20 March)


Standard Summit Ticket



Sponsorship Opportunities

  • Gain access to 150 Senior Executives from the Digital Health Industry, who will be attending the event;
  • Brand alignment with the FT and its unrivalled credibility;
  • Demonstrate thought leadership around the current critical issues affecting the healthcare industry;
  • Benefit from sustained international visibility through our advertising and marketing campaigns

Joe Hames

Commercial Manager, Global Industries

T: +44 (0)207 873 4551

M: +44 (0)791 329 2038




Estrel Berlin
Sonnenallee 225
Berlin 12057


Tel: +49 30 68310


Presented By (1)

The Financial Times is one of the world’s leading business news organisations, recognised internationally for its authority, integrity and accuracy. In 2016 the FT passed a significant milestone in its digital transformation as digital and services revenues overtook print revenues for the first time. The FT has a combined paid print and digital circulation of more than 910,000 and makes 60% of revenues from its journalism.

Photos from 2017 FT Digital Health Summit Europe

Please click on this link to access photos from our 2017 summit. 


34767220674_5d6565ac36_m (1)



Lead sponsors (2)

ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, and to government. The company specialises in the strategic development, management and analysis of programs that support clinical development. ICON offers a full range of consulting, development and commercialisation services that help clients to accelerate the development of drugs and devices that save lives and improve quality of life.

Through its fully integrated Commercialisation & Outcomes services, ICON delivers resources and expertise to identify, generate, synthesize and communicate treatment safety and value, to help regulators, payers, providers and patients make informed health decisions.

With headquarters in Dublin, Ireland, ICON currently, operates from 97 locations in 38 countries and has approximately 13,250 employees. For further information please visit Follow @iconplc on Twitter.

Intel is a world leader in the design and manufacturing of essential products and technologies that power the cloud and an increasingly smart, connected world. Intel delivers computer, networking, and communications platforms. We are expanding the boundaries of technology through our relentless pursuit of Moore’s Law and computing breakthroughs that make amazing experiences possible. To learn more on our work in healthcare, visit or follow us on Twitter @IntelHealth.

Knowledge Partner (1)

Associate Sponsor (1)

Supporting Partner (2)

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 33 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world. is a comprehensive print, digital and social media platform dedicated to promoting management, leadership, best practice and cross-collaboration in healthcare. With the active engagement from thought leaders and well-respected national and international associations, HealthManagement provides comprehensive information related to clinical practice, hospital administration, latest research, technology advances, major practice challenges and valuable management ti

Contact Us

Alexsandra Silva
Media Partner and Press Enquiries
Financial Times
Ailsa Matkevich
Speaking Opportunities
Financial Times
Joe Hames
Sponsorship Opportunities
Financial Times
Toby Barran
Delegate Booking and Registration Enquiries
Financial Times